CONTACT TRANSSCLERAL CYCLOPHOTOCOAGULATIO N - MIDTERM RESULTS

Transscleral contact cyclophotocoagulation with ND YAG Laser continuou s mode permits the induction of a focused ciliary process with a secre tory surface decrease. This treatment has been used for the treatment of refractory glaucoma since 1987. We report the treatment by transscl eral cyclophotocoagulation of 49 patients with terminal glaucoma. All 49 patients had a measurable visual acuity and an elevated intraocular pressure under maximal medical treatment. None could be operated by t rabeculectomy. The origin of the glaucoma was neovascular (26 patients ), open angle glaucoma (9 patients) secondary glaucoma (14 patients). 62.2 % of the patients had an intraocular pressure less-than-or-equal- to 25 mm after 6 months ; 8 % showed decrease visual acuity. We descri be the complications of the treatment and compare the efficacy of trea tment depending on the origin of the glaucoma : neovascular or not.